CELFULL Showcases Aging Intervention Technology at SupplySide Global to Lead New Trends 2026

LAS VEGAS–(BUSINESS WIRE)–The recently concluded SupplySide Global 2025 was hailed as “the best ever” by a senior dietary supplement expert, who highlighted bioavailability as the defining frontier for health supplements in 2026. As “high content” gives way to “high absorption,” CELFULL – a clinically driven anti-aging health brand – unveiled Celfavor NADH, a controlled-release microsphere … [Read more…]

GE HealthCare management to present at upcoming investor conference

CHICAGO–(BUSINESS WIRE)–GE HealthCare (Nasdaq: GEHC) management will present at the following upcoming investor conference. Jefferies Global Healthcare Conference in London, England – Tuesday, November 18, 2025 at 9:30 am GMT/4:30 am ET/3:30 am CT GE HealthCare’s CFO, Jay Saccaro, will discuss a variety of topics related to business strategy and growth opportunities. He will also … [Read more…]

Masimo Issues Statement on California Jury Verdict Finding Patent Infringement by Apple and Awarding Masimo $634 Million in Damages

IRVINE, Calif.–(BUSINESS WIRE)–Masimo (NASDAQ: MASI) today issued the following statement in response to the jury verdict announced in the U.S. District Court for the Central District of California, which confirmed the validity of Masimo Patent No. 10,433,776, found Apple infringed this patent, and awarded Masimo $634 million in damages: “We are pleased by this outcome, … [Read more…]

Repare Therapeutics Enters into Definitive Agreement to be Acquired by XenoTherapeutics, Inc.

– Each shareholder is estimated to receive US$1.82 per share plus one CVR per common share – – Transaction expected to close in the first quarter of 2026 – – Additional portfolio monetization efforts continue – – Company reports 3Q 2025 financial results – – $112.6 million in cash and cash equivalents and marketable securities … [Read more…]

HealthView CEO Steven Gonzalez Publishes First Inc. Article, “3 Leadership Lessons From Surfing,” — With a Follow-Up Feature to Be Released Soon

CERRITOS, Calif.–(BUSINESS WIRE)–HealthView is proud to announce that its Chief Executive Officer, Steven Gonzalez, has published his first article in Inc. Magazine, marking an important milestone for the organization’s expanding leadership voice. His debut piece, “3 Leadership Lessons From Surfing,” explores how the uncertainty of the ocean mirrors the realities of modern leadership—highlighting adaptability, balance, … [Read more…]

Healthfirst Empowers New Yorkers at Diabetes Health Education Events

Community Event at SBH Health & Wellness Center Supports Bronx Residents During Diabetes Prevention Month BRONX, N.Y.–(BUSINESS WIRE)–Healthfirst, a leading not-for-profit health plan serving more than two million New Yorkers, today is hosting a community event focused on diabetes prevention and management at SBH Health & Wellness Center in the Bronx. This forum, co-hosted with … [Read more…]

Satellos Reports Third Quarter 2025 Results and Announces Appointment of Mark Nawacki to Board of Directors

Appointed Mark Nawacki, seasoned M&A expert, co-founder, president & former CEO of Searchlight Pharma, to Board of Directors Completed IND submission to the U.S. FDA and global regulatory filings to advance a Phase 2 clinical trial of SAT-3247 in children with Duchenne muscular dystrophy (DMD) Dosed first patient in open-label, long-term follow-up study (LT-001) of … [Read more…]

Galderma Completes Successful Placement of CHF 175 Million Bond

ZUG, Switzerland–(BUSINESS WIRE)–NOT FOR DISTRIBUTION IN THE UNITED STATES OR IN ANY OTHER JURISDICTION IN WHICH SUCH DISTRIBUTION WOULD BE RESTRICTED BY APPLICABLE LAW OR REGULATION. Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced the successful placement of a single-tranche CHF 175 million Swiss franc-denominated bond. The bond has a maturity of … [Read more…]

TandemAI Closes $22M Series A Extension Round to Accelerate AI-Driven Drug Discovery

NEW YORK & BOSTON–(BUSINESS WIRE)–TandemAI announced it has secured a $22 million Series A extension to further develop its drug discovery platform, which combines advanced AI, physics-based computational methods, and wet lab capabilities. The round included both new and existing investors. Since its founding in October 2021, the company has raised over $80M. With a … [Read more…]